DTHC/F CELEBRATES NEWS THAT LONG-ACTING INJECTABLE PrEP IS SAFE AND EFFECTIVE IN PREVENTING HIV INFECTION IN AFRICAN WOMEN

10 November 2020 – The Desmond Tutu HIV Centre and Health Foundation welcome the announcement that another trial of long-acting injectable antiretroviral cabotegravir has demonstrated safety and efficacy in the prevention of HIV in cisgender women in Africa. Study sponsors ViiV, NIAID and the HPTN  announced yesterday that the randomised part of the landmark trial…

SA’s latest COVID-19 vaccine trial crucial for future access

*The following press release was published by African Alliance on Monday 09 November 2020.   South Africa’s newest COVID-19 vaccine trial is another crucial step in ensuring a future vaccine works for South Africans and should be commended, says advocacy group the African Alliance and partner, the Vaccine Advocacy Resource Group. “Historically, Africa has had…